Germain, DP;
Falissard, B;
Hilz, MJ;
Spada, M;
Wanner, C;
Elliott, PM;
(2019)
Response to Gurevich and colleagues: The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: a systematic literature review by a European panel of experts.
Molecular Genetics and Metabolism Reports
, 20
, Article 100493. 10.1016/j.ymgmr.2019.100493.
Preview |
Text
1-s2.0-S2214426919300977-main.pdf - Published Version Download (354kB) | Preview |
| Type: | Article |
|---|---|
| Title: | Response to Gurevich and colleagues: The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: a systematic literature review by a European panel of experts |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.ymgmr.2019.100493 |
| Publisher version: | https://doi.org/10.1016/j.ymgmr.2019.100493 |
| Language: | English |
| Additional information: | Copyright © 2019 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/). |
| Keywords: | Agalsidase alfa, Agalsidase beta, Enzyme replacement therapy, Fabry disease |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science > Clinical Science |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10081036 |
Archive Staff Only
 |
View Item |
